Skip to main content
OpenTrials
Completed

NCT Number: NCT02741843

Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly

The purpose of this study is to test the effectiveness of brief face-to-face patient education in increasing uptake of influenza vaccine among Chinese elderly in the community.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cantonese speaking
  • Chinese

Exclusion criteria

  • cognitively impaired
  • unable to communicate effectively
  • having known contraindication of vaccination
  • institutionalized

Treatment and study plan

Patient education

Behavioral

Primary outcomes

  1. proportion of patients receiving influenza vaccination

    Time frame: three working days

Secondary outcomes

  1. proportion of patients receiving influenza vaccination

    Time frame: five working days

  2. proportion of patients receiving influenza vaccination

    Time frame: seven working days

  3. proportion of patients receiving influenza vaccination

    Time frame: nine working days

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Official study title

Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly: A Randomised Controlled Trial

Important dates

Study start
2015
Primary completion
2015
First posted
Apr 18, 2016
Registry last updated
May 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.